Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 259

Spero shoots through series C target

GV has led a consortium that included Osage University Partners in an overubscribed round that closed at $51.7m.

Mar 10, 2017

Biohaven closes $80m series A

The Yale spinout has closed an oversubscribed $80m funding round that featured Osage University Partners and Connecticut Innovations, boosting its total funding to $100m.

Mar 8, 2017

PMV diagnoses $74m series B

Osage University Partners has taken part in a series B round for PMV Pharmaceuticals.

Mar 1, 2017

Therarchon boosts series A to $40m

Bpifrance has joined a consortium of investors that already featured Inserm Transfer Initiative and that previously provided $35m in funding.

Jan 6, 2017

Tenaya heartened by $50m series A

A spinout from UCSF affiliate Gladstone Institutes, Tenaya secured funding from VC firm Column Group to develop cures for heart disease.

Dec 7, 2016

Investors transplant $48.5m into Magenta series A

Biotechnology developer Magenta Therapeutics, which exploits Harvard research, has launched with series A funding provided by investors including Alphabet.

Nov 17, 2016

Emulate expands series B to $45m

The Harvard spinout has increased a round already backed by Cedars-Sinai and LabCorp from $28m to $45m following an extension provided by unnamed new investors.

Oct 24, 2016

Oblong enters $65m orbit

Based on research conducted at MIT Media Lab, Oblong Industries is developing spatial, gesture-enabled technologies and has now added Utimco to its shareholders.

Oct 19, 2016
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here